Clinical Trials Directory

Trials / Completed

CompletedNCT03748160

Herd Immunity and Influenza Vaccine Uptake

Herd Immunity Communication and Influenza Vaccine Uptake

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48,125 (actual)
Sponsor
Finnish Institute for Health and Welfare · Other Government
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to test the effectiveness of communicating the concept of herd immunity on actual influenza vaccine uptake using a randomized controlled trial.

Detailed description

The investigators run a large-scale randomized controlled trial (RCT) to understand behavioural processes that guide decisions to vaccinate and test alternative strategies to communicate the concept of herd immunity. The experiment varies the text of postal letters send to individuals eligible for free influenza vaccines. The experiment is run in collaboration with the municipal health authorities. The investigators identify from the Population Register all individuals who are born in year 1953 or before and resided in the participating municipality on October 01, 2018. The investigators will obtain the postal addresses of these individuals using the Population Register and randomly assign individuals to treatment conditions that differ in the wording of the information material and reception of a text message. Importantly, the extract from the Population Register will also include an individual identifier (social security number) that can be used to match the received type of letter (treatment) with the actual vaccination decision recorded in the Care Register for Health Care to objectively evaluate the impact of received information on vaccine uptake. The matching of postal addresses and vaccination data will be conducted using pseudonymized identifiers. The pseudonymization of individual identifiers will be performed separately for both datasets by professional data management and data security staff of the National Institute for Health and Welfare. The investigators conducting the data analysis will be able to access only pseudonymous data without a possibility to directly identify individuals from the data set. The data will be stored according to the data protection legislation and regulations of the National Institute for Health and Welfare during the research project. The investigators randomly assign individuals to treatment conditions that differ in the wording of the letters. The authority's standard letter serves as the baseline condition (T1). This letter is extended by communicating the concept of herd immunity and appealing to pro-social preferences by highlighting the fact that vaccinations may effectively prevent infections among people who are not able to vaccinate themselves (especially babies) (T2). To summarize, this study includes a control treatment (T0, no letter) and two active treatment arms with the following contents: T1 (Mailing) - Standard letter T2 (Herd) - Herd immunity letter

Conditions

Interventions

TypeNameDescription
OTHERLetterIntervention consists of two different types of postal letters reminding elderly citizens (65 years and above) about influenza vaccines that are available free of charge from the local health centers

Timeline

Start date
2018-10-01
Primary completion
2019-06-01
Completion
2019-12-31
First posted
2018-11-20
Last updated
2025-08-20

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT03748160. Inclusion in this directory is not an endorsement.